Floatz logo

Allo-Mscs

Cardiomyopathy Due to Anthracyclines

The University of Texas Health Science Center, HoustonCell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Cardiomyopathy Due to Anthracyclines cohort.

Asset / SponsorPhaseRating
Rosuvastatin
Shiraz University of Medical Sciences
Phase 4BB
Dapagliflozin
University Medical Centre Ljubljana
Phase 2CCC
Sotagliflozin
Icahn School of Medicine at Mount Sinai
Phase 2CCC
SFX-01 (SULFORAPHANE STABILIZED WITH .ALPHA. CYCLODEXTRIN)
Texas Tech University Health Sciences Center
Phase 1/2CCC

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →